Biosimilars

Millions of people with diabetes simply can’t live without insulin. Discovered over a century ago, it’s patent was sold for $1. But today, pharmaceutical corporations have arbitrarily raised insulin prices, leaving those who can’t afford it having to ration it–or worse, go without it. Abdul breaks down why insulin has become the epitome of pharmaceutical company greed. Then he talks to the leaders of T1International, a non-profit dedicated to insulin access, about how to ensure access.

For a transcript of this episode, please visit crooked.com/americadissected